Avrupa Yatirim Holding AS

The company's capital structure is characterized by a debt-to-equity ratio of 0.19, indicating a relatively low level of leverage. The liquidity position is marked by a current ratio of 1.75, suggesting the company has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash is negative after subtracting total debt, which may pose a liquidity risk. In terms of profitability, the company's return on equity (ROE) is 29.63%, and return on assets (ROA) is 14.41%, both of which are strong indicators of efficient use of equity and assets. Despite a negative gross profit and operating income, the company reported a net income of 325,636,450 TRY, which is a significant figure. The company's profitability metrics are compared against industry benchmarks, and while the ROE and ROA are favorable, the negative gross and operating profits suggest operational inefficiencies or high costs. The company's revenue is concentrated in Turkey, with exports to Ukraine, Russia, Romania, and Poland. The geographic exposure is limited, and the company does not disclose specific revenue by region, which may indicate a lack of diversification. The company's segments include manufacturing and health services, with the latter being a recent acquisition. The growth trajectory of the company is not clearly defined, as the outlook for the current and next fiscal years does not provide specific numeric deltas. The company's revenue history shows a significant net income despite negative operating and gross profits, which may indicate non-operational income sources or one-time gains. The risk assessment indicates a medium liquidity risk and low dilution risk, but the negative net cash after debt is a concern. Recent events include the acquisition of Gulden Saglik Hizmetleri Ticaret A.S and Valide Etfal Ozel Saglik Hizmetleri Medikal Insaat Gida Sanayi ve Ticaret Limited in August 2014. These acquisitions expanded the company's operations into health services and medical construction. The company's financial filings and transcripts do not provide additional details on recent strategic moves or operational changes.